Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer
This study has been withdrawn prior to enrollment.
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Cephalon )
First received: March 15, 2012
Last updated: August 14, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||January 2018|
|Estimated Primary Completion Date:||May 2016 (Final data collection date for primary outcome measure)|